17681-30-0 Usage
General Description
Benzothiazol-2-ylmethyl-methyl-amine is a chemical compound that belongs to the chemical class called organosulfur compounds, which contain sulfur and have a wide variety of industrial applications. Its molecular formula is C9H10N2S and commonly exists as a pale-yellow to dark-brown crystalline solid. It's primarily used in chemical synthesis for preparing pharmaceutical products, although specific details about its exact use and properties are limited. It must be handled carefully due to potential hazards associated with many organic and organosulfur compounds. As with all chemical substances, proper precautions should be taken when handling it to protect against potential health and safety risks.
Check Digit Verification of cas no
The CAS Registry Mumber 17681-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,6,8 and 1 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 17681-30:
(7*1)+(6*7)+(5*6)+(4*8)+(3*1)+(2*3)+(1*0)=120
120 % 10 = 0
So 17681-30-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2S/c1-10-6-9-11-7-4-2-3-5-8(7)12-9/h2-5,10H,6H2,1H3/p+1
17681-30-0Relevant articles and documents
tert-Butoxy-Radical-Promoted α-Arylation of Alkylamines with Aryl Halides
Ueno, Ryota,Ikeda, Yuko,Shirakawa, Eiji
supporting information, p. 4188 - 4193 (2017/08/07)
In the presence of a tert-butoxy radical precursor, the reaction of alkylamines with aryl halides was found to give α-arylated alkylamines through homolytic aromatic substitution of the halogen atoms.
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FATTY ACID BIOSYNTHESIS FOR BACTERIAL INFECTIONS
-
Page/Page column 9, (2013/04/10)
The present invention relates to novel heterocyclic compounds which specifically inhibit bacterial Fab I and can be used for the treatment of Staphylococcal infections.
Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
-
, (2008/06/13)
Vitronectin receptor antagonists having the formula: STR1 which are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as osteoporsis.
